Either way, the mechanistic worry I raised in June is resolved
We studied 14,814 patientshalf with type 2 diabetes and the other half without diabetes
At En Vogue IV Therapy & Wellness, we believe in offering personalized treatments that support your overall health and well-being
Several factors make RUO GLP-1 sales especially risky: The compounds are identical to approved drugs Demand is driven by widespread consumer and clinical use, not niche research Sales volumes often exceed what would be expected for legitimate laboratory research Buyers frequently include wellness clinics, telehealth providers, and resellers rather than research institutions When these facts are present, RUO disclaimers carry little weight
You need baseline labs, periodic monitoring, and a provider who can intervene if something goes wrong
Available from: Dharmalingam M